上尿路尿路上皮癌的淋巴清扫术进展研究
Discussion on the Lymphnode Dissection of Upper Tract Urothelial Carcinoma
DOI: 10.12677/ACM.2023.133479, PDF,   
作者: 王天童：云南中医药大学第一临床医学院，云南 昆明；杨 萌, 王春晖*：昆明医科大学附属延安医院，云南 昆明
关键词: 淋巴清扫；上尿路尿路上皮癌；外科治疗；Lymphadenectomy； Upper Urinary Tract Urothelial Carcinoma； Surgical Treatment
摘要: 目的：上尿路尿路上皮癌(Upper Tract Urothelial Carcinoma, UTUC)患者在接受根治性肾输尿管切除术合并膀胱袖状切除术时，行区域淋巴结清扫术是否能给患者带来生存益处存在很大的争议。我们将通过这篇综述探讨淋巴清扫术带来的肿瘤学相关益处及风险。方法：通过阅读近十年的相关文献，从资料与方法等方面进行综述。结论：目前无有力证据表明淋巴清扫术(Lymphnode Dissection, LND)能改善UTUC患者的预后，但其可以增加病理分期的准确性并有助于制定辅助治疗策略及个体化随访，在高危患者中行LND对于患者后续治疗方案的选择有着重要的指示意义。
Abstract: Object: There is a great argument in terms of whether the regional lymph node dissection (LND) is able to bring the survival benefits to patients with urothelial carcinoma in upper urinary tract when undergoing radical nephroureterectomy with bladder cuff excision. We will discuss the oncologic benefits and risks associated with lymphatic dissection in this review. Methods: The related litera-ture of the recent ten years was reviewed from the aspects of materials and methods. Conclusions: There is no strong evidence that lymphnode dissection can improve the survival rate of most pa-tients. However, it can increase the accuracy of pathological staging and help to develop adjuvant treatment strategies and individualized follow-up treatment. The application of LND in high-risk patients has important indicative significance for the selection of follow-up treatment.
文章引用：王天童, 杨萌, 王春晖. 上尿路尿路上皮癌的淋巴清扫术进展研究[J]. 临床医学进展, 2023, 13(3): 3370-3376. https://doi.org/10.12677/ACM.2023.133479

参考文献

[1] Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
[2] Rouprêt, M., Babjuk, M., Compérat, E., et al. (2017) EEuropean Associa-tion of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. European Urology, 73, 111-122. [Google Scholar] [CrossRef] [PubMed]
[3] Soria, F., Shariat, S.F., Lerner, S.P., et al. (2017) Epidemiology, Diagnosis, Preoperative Evaluation and Prognostic Assessment of Upper-Tract Urothelial Carcinoma (UTUC). World Journal of Urology, 35, 379-387. [Google Scholar] [CrossRef] [PubMed]
[4] Fajkovic, H., Cha, E.K., Jeldres, C., et al. (2012) Prognostic Val-ue of Extranodal Extension and Other Lymph Node Parameters in Patients with Upper Tract Urothelial Carcinoma. The Journal of Urology, 187, 845-851. [Google Scholar] [CrossRef] [PubMed]
[5] Chan, V.W.S., Wong, C.H.M., Yuan, Y. and Teoh, J.Y.C. (2021) Lymph Node Dissection for Upper Tract Urothelial Carcinoma: A Systematic Review. Arab Journal of Urology, 19, 37-45. [Google Scholar] [CrossRef] 
[6] 周利群, 张雷. 上尿路尿路上皮癌临床诊疗关键及争议问题[J]. 中华泌尿外科杂志, 2017, 38(12): 881-884.
[7] Roscigno, M., Shariat, S.F., Margulis, V., et al. (2009) Impact of Lymph Node Dissection on Cancer Specific Survival in Patients with Upper Tract Urothelial Carcinoma Treat-ed with Radical Nephroureterectomy. The Journal of Urology, 181, 2482-2489. [Google Scholar] [CrossRef] [PubMed]
[8] Fajkovic, H., Cha, E.K., Jeldres, C., et al. (2012) Prognostic Value of Extranodal Extension and Other Lymph Node Parameters in Patients with Upper Tract Urothelial Carcinoma. The Journal of Urology, 187, 845-851. [Google Scholar] [CrossRef] [PubMed]
[9] Lughezzani, G., Jeldres, C., Isbarn, H., et al. (2010) A Critical Ap-praisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma. Urology, 75, 118-124. [Google Scholar] [CrossRef] [PubMed]
[10] Zareba, P., Rosenzweig, B., Winer, A.G. and Coleman, J.A. (2017) Association Between Lymph Node Yield and Survival Among Patients Undergoing Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Tract. Cancer, 123, 1741-1750. [Google Scholar] [CrossRef] [PubMed]
[11] Singla, N., Fang, D., Su, X., et al. (2017) A Multi-Institutional Compari-son of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States. The Journal of Urology, 197, 1208-1213. [Google Scholar] [CrossRef] [PubMed]
[12] 中国医师协会泌尿外科医师分会上尿路尿路上皮癌(CUDA-UTUC)协作组. 上尿路尿路上皮癌外科治疗中国专家共识[J]. 现代泌尿外科杂志, 2018, 23(11): 826-829.
[13] 方冬, 周利群. 2020版EAU膀胱癌指南更新解读之三——上尿路尿路上皮癌诊疗进展[J]. 中华泌尿外科杂志, 2020, 41(8): 573-574.
[14] Kondo, T., Nakazawa, H., Ito, F., Hashimoto, Y., Toma, H. and Tanabe, K. (2007) Primary Site and Incidence of Lymph Node Metastases in Urothelial Carcinoma of Upper Urinary Tract. Urology, 69, 265-269. [Google Scholar] [CrossRef] [PubMed]
[15] Kondo, T. and Tanabe, K. (2012) Role of Lymphadenectomy in the Management of Urothelial Carcinoma of the Bladder and the Upper Urinary Tract. International Journal of Urology, 19, 710-721. [Google Scholar] [CrossRef] [PubMed]
[16] Kondo, T., Nakazawa, H., Onitsuka, S., et al. (2005) 97: Primary Site and Incidence of Lymph Node Metastases in Urothelial Carcinoma of the Upper Urinary Tract. The Journal of Urology, 173, 27. [Google Scholar] [CrossRef] 
[17] Assouad, J., Riquet, M., Foucault, C., Hidden, G. and Del-mas, V. (2006) Renal Lymphatic Drainage and Thoracic Duct Connections: Implications for Cancer Spread. Lymphology, 39, 26-32.
[18] Matin, S.F., Sfakianos, J.P., Espiritu, P.N., Coleman, J.A. and Spiess, P.E. (2015) Patterns of Lym-phatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates. The Journal of Urology, 194, 1567-1574. [Google Scholar] [CrossRef] [PubMed]
[19] Rouprêt, M., Babjuk, M., Burger, M., et al. (2021) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. European Urology, 79, 62-79. [Google Scholar] [CrossRef] [PubMed]
[20] Cho, K.S., Choi, H.M., Koo, K., et al. (2009) Clinical Significance of Lymph Node Dissection in Patients with Muscle-Invasive Upper Urinary Tract Transitional Cell Carci-noma Treated with Nephroureterectomy. Journal of Korean Medical Science, 24, 674-678. [Google Scholar] [CrossRef] [PubMed]
[21] Miyake, H., Hara, I., Gohji, K., Arakawa, S. and Kamidono, S. (1998) The Significance of Lymphadenectomy in Transitional Cell Carcinoma of the Upper Urinary Tract. British Journal of Urology, 82, 494-498. [Google Scholar] [CrossRef] 
[22] Brausi, M.A., et al. (2007) Retroperitoneal Lymph Node Dissection (RPLD) in Conjunction with Nephroureterectomy in the Treatment of Infiltrative Transitional Cell Carcinoma (TCC) of the Upper Urinary Tract: Impact on Survival. European Urology, 52, 1414-1420. [Google Scholar] [CrossRef] [PubMed]
[23] Dominguez-Escrig, J.L., Peyronnet, B., Seisen, T., et al. (2017) Potential Benefit of Lymph Node Dissection during Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-Muscle-Invasive Bladder Can-cer. European Urology Supplements, 17, e1721. [Google Scholar] [CrossRef] 
[24] Choo, M.S., Yoo, S., Yuk, H.D., et al. (2020) Survival Benefits Based on the Number of Lymph Nodes Removed during Radical Nephroureterectomy for Upper Tract Urotheli-al Carcinoma: Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 9, Article No. 1933. [Google Scholar] [CrossRef] [PubMed]
[25] Roscigno, M., Shariat, S.F., Freschi, M., et al. (2009) Assessment of the Minimum Number of Lymph Nodes Needed to Detect Lymph Node Invasion at Radical Nephroureterectomy in Patients with Upper Tract Urothelial Cancer. Urology, 74, 1074-1075. [Google Scholar] [CrossRef] [PubMed]
[26] Winer, A.G., Vertosick, E.A., Ghanaat, M., et al. (2017) Prog-nostic Value of Lymph Node Yield during Nephroureterectomy for Upper Tract Urothelial Carcinoma. Urologic Oncol-ogy: Seminars and Original Investigations, 35, 151.e9-151.e15. [Google Scholar] [CrossRef] [PubMed]
[27] 李志勇, 刘卓炜. 上尿路尿路上皮癌的围手术期治疗现状[J]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(5): 326-329.
[28] Rao, S.R., Correa, J.J., Sexton, W.J., et al. (2012) Prospective Clinical Trial of the Feasibility and Safety of Modified Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carci-noma. BJU International, 110, E475-E480. [Google Scholar] [CrossRef] 
[29] Kondo, T., Hashimoto, Y., Kobayashi, H., et al. (2010) Template-Based Lymphadenectomy in Urothelial Carcinoma of the Upper Urinary Tract: Impact on Patient Survival. International Journal of Urology, 17, 848-854. [Google Scholar] [CrossRef] [PubMed]
[30] Catto, J.W.F., Yates, D.R., Rehman, I., et al. (2007) Be-havior of Urothelial Carcinoma with Respect to Anatomical Location. The Journal of Urology, 177, 1715-1720. [Google Scholar] [CrossRef] [PubMed]
[31] Catto, J.W.F., Hartmann, A., Stoehr, R., et al. (2006) Multifocal Urothelial Cancers with the Mutator Phenotype are of Monoclonal Origin and Require Panurothelial Treatment for Tumor Clearance. The Journal of Urology, 175, 2323-2330. [Google Scholar] [CrossRef] 
[32] Gschwend, J.E., Heck, M.M., Lehmann, J., et al. (2019) Ex-tended versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. European Urology, 75, 604-611. [Google Scholar] [CrossRef] [PubMed]
[33] Touijer, K., Sjoberg, D., Benfante, N., et al. (2019) MP54-10 Comparison between Limited and Extended Lymph Node Dissection for Prostate Cancer: Results from a Large, Clinical-ly-Integrated, Randomized Trial. The Journal of Urology, 201, e788. [Google Scholar] [CrossRef] 
[34] Giuliano, A.E., Ballman, K.V., Mccall, L., et al. (2017) Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival among Women with Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA, 318, 918-926. [Google Scholar] [CrossRef] [PubMed]
[35] 袁易初, 黄吉炜, 蔡彪, 陈勇辉, 张进, 陈海戈, 薛蔚, 黄翼然. 肿瘤大小对806例行根治手术的上尿路尿路上皮癌患者预后的分析[J]. 临床泌尿外科杂志, 2019, 34(4): 274-279.

为你推荐